The meaning of quality of life in patients being treated for advanced breast cancer: A qualitative study

被引:111
作者
Luoma, ML [1 ]
Hakamies-Blomqvist, L [1 ]
机构
[1] Univ Helsinki, Dept Psychol, FIN-00014 Helsinki, Finland
关键词
D O I
10.1002/pon.788
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of the present study was to investigate the meaning of advanced breast cancer patients! quality of life (QoL). A semi-structured interview was used, and the phenomenological research method chosen to analyse the data. The findings show that limitations in physical functioning translate into dependency on others, leading to decreased autonomy. Patients tended to ensure their autonomy by participating in easier activities or changing their internal standards. Changes in appearance and decreased condition affected patients' ability to carry out roles and responsibilities, which led to changes in lifestyle and also affected patients' social functioning, often resulting in isolation. The meaning of being able to sustain reciprocal relationships was emphasized. Patients maintained control of to what extent their illness was recognized in social relationships, which was crucial to their feelings of autonomy. Close families were a main source of social support, but also a major source of concern. Meaning of emotional functioning was often expressed in terms of the ability to enjoy life day-by-day and of commitment to treatment. Patients' cognitive functioning was largely intact while their difficulties in cognitive functioning were more characteristic of anxiety. Global QoL was often expressed in terms of a normal life. In addition there were 3 meta themes which emerged from the data: the patients' ability to control the illness experience, personal growth and hope. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码:729 / 739
页数:11
相关论文
共 19 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   A substantive theory of quality of life of adults with chronic leukaemia [J].
Bertero, C ;
Eriksson, BE ;
Ek, AC .
INTERNATIONAL JOURNAL OF NURSING STUDIES, 1997, 34 (01) :9-16
[3]   Quality of life in patients undergoing systemic therapy for advanced breast cancer [J].
Bottomley, A ;
Therasse, P .
LANCET ONCOLOGY, 2002, 3 (10) :620-628
[4]   Quality of life measurement: bibliographic study of patient assessed health outcome measures [J].
Garratt, AN ;
Schmidt, L ;
Mackintosh, A ;
Fitzpatrick, R .
BMJ-BRITISH MEDICAL JOURNAL, 2002, 324 (7351) :1417-1419
[5]  
GIORGI A, 1996, PHENOMENOLOGY PSYCHO
[6]   Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil.: A multicentre randomised phase III trial by the Scandinavian Breast Group [J].
Hakamies-Blomqvist, L ;
Luoma, ML ;
Sjöström, J ;
Pluzanska, A ;
Sjödin, M ;
Mouridsen, H ;
Ostenstad, B ;
Mjaaland, I ;
Ottosson-Lönn, S ;
Bergh, J ;
Malmström, PO ;
Blomqvist, C .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (11) :1411-1417
[7]   The evolving experience of illness for Chinese women with breast cancer: A qualitative study [J].
Lam, WWT ;
Fielding, R .
PSYCHO-ONCOLOGY, 2003, 12 (02) :127-140
[8]  
Landmark BT, 2001, CANCER NURS, V24, P220, DOI 10.1097/00002820-200106000-00008
[9]   Meaning of illness for women with breast cancer [J].
Luker, KA ;
Beaver, K ;
Leinster, SJ ;
Owens, RG .
JOURNAL OF ADVANCED NURSING, 1996, 23 (06) :1194-1201
[10]   Physical performance, toxicity, and quality of life as assessed by the physician and the patient [J].
Luoma, ML ;
Hakamies-Blomqvist, L ;
Sjöström, J ;
Mouridsen, H ;
Pluzanska, A ;
Malmstrom, P ;
Bengtsson, NO ;
Hultborn, R ;
Ostenstaad, B ;
Mjaaland, I ;
Valvere, V ;
Wist, E ;
Baldursson, G ;
Ahlgren, J ;
Blomqvist, C .
ACTA ONCOLOGICA, 2002, 41 (01) :44-49